News
MODTX: Phase IIa CKD study progressed on plan, with financials bolstered by a major warrant exercise
8+ hour, 17+ min ago (76+ words) Trading View MODTX: Phase IIa CKD study progressed on plan, with financials bolstered by a major warrant exercise Q1 2026 saw continued execution of the Phase IIa CKD with anemia study, improved loss per share, and a strengthened financial position following a…...
Noxopharm Says New Data Confirms Cancer-Fighting Potential
12+ hour, 17+ min ago (21+ words) Trading View Noxopharm Says New Data Confirms Cancer-Fighting Potential More news from Reuters...
aether AI Co. , Ltd. Statistics " TPEX: 7803 " Trading View
10+ hour, 14+ min ago (116+ words) Aetherai Co. Ltd. provides artificial intelligence medical imaging services. It offers whole slide image solutions for pathology. Its product portfolio development is based on the following two-pronged approach: Making Whole-Slide Image Solutions standard for routine pathology for integration of AI…...
Mini Med to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
1+ hour, 34+ min ago (114+ words) Trading View Mini Med to Participate in Goldman Sachs 47th Annual Global Healthcare Conference NORTHRIDGE, Calif. , May 26, 2026 /PRNewswire/ -- Mini Med (Nasdaq: MMED), a global leader in diabetes technology, today announced that management will participate in a fireside chat at the upcoming…...
Editas Medicine Presents EDIT-401 Preclinical Data Showing ~90% Cuts in LDL-C, Lp(a), and Apo B; CTN Planned Mid-2026
4+ hour, 6+ min ago (193+ words) Trading View Editas Medicine Presents EDIT-401 Preclinical Data Showing ~90% Cuts in LDL-C, Lp(a), and Apo B; CTN Planned Mid-2026 Editas Medicine reported that a single dose of EDIT-401 produced ~90% mean reductions in LDL-C, Lp(a) and Apo B in non-human primates and…...
Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
2+ hour, 39+ min ago (41+ words) Trading View Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer More news from Reuters...
Working capital per share of aether AI Co. , Ltd. " TPEX: 7803 " Trading View
12+ hour, 7+ min ago (93+ words) Aetherai Co. Ltd. provides artificial intelligence medical imaging services. It offers whole slide image solutions for pathology. Its product portfolio development is based on the following two-pronged approach: Making Whole-Slide Image Solutions standard for routine pathology for integration of AI…...
Osteopore Receives Hainan FDA Approval For Orthopaedic Custom Medical Devices
13+ hour, 3+ min ago (25+ words) Trading View Osteopore Receives Hainan FDA Approval For Orthopaedic Custom Medical Devices More news from Reuters...
ONCOZ: Phase III trial for Bupi Zenge" nears EMA approval as liquidity is bolstered by new investments
8+ hour, 18+ min ago (83+ words) Trading View ONCOZ: Phase III trial for Bupi Zenge" nears EMA approval as liquidity is bolstered by new investments Regulatory acceptance for the Phase III trial of Bupi Zenge" was achieved, with full EMA approval expected by late May 2026 and…...
Return on assets % of aether AI Co. , Ltd. " TPEX: 7803 " Trading View
8+ hour, 24+ min ago (93+ words) Aetherai Co. Ltd. provides artificial intelligence medical imaging services. It offers whole slide image solutions for pathology. Its product portfolio development is based on the following two-pronged approach: Making Whole-Slide Image Solutions standard for routine pathology for integration of AI…...